Answers are grounded in this paper and cite their sources.
Introduction Many neurodevelopmental disorders with intellectual disability and autism spectrum disorder syndromes have overlapping genetic and molecular connections. Effective treatments for such genetic neurodevelopmental disorders have not been established yet. Possible reasons include the lack of suitable disease models of human neurons and a limited understanding of the etiological and neurobiological mechanisms of the brain. The reprogramming technology of somatic cells allows the generation of induced pluripotent stem cells from the patients’ fibroblasts that subsequently differentiate into neuronal cells carrying the genetic variations that cause the specific disorders. Investigation into monogenic neurodevelopmental disorders has proved advantageous in their analysis, and there are a number of successful reports that have been published. This approach has a promising potential, but some technical caveats need to be addressed like the variability observed between cell lines that emerge after reprogramming. Another challenge involves differentiating the reprogrammed cells into cell types that are implicated in the disease phenotypes, with minimum heterogeneity and variability. Modelling monogenic neurological disorders with genetic mutations has been successful and is considered as a basic tool for establishing functional human neurons to reveal disease specific phenotypes. This critical review discusses the use of cellular reprogramming to study intellectual disability and neurodevelopmental disorders. Conclusion Methodology and analysis need to be improved to detect important differences between controls and patients’ cell lines. Technology has been improving over the last few years. Studies with improved induced pluripotent stem cell technologies in diseases that show highly penetrant and early onset syndromes, such as Smith-Magenis syndrome, PotockiLupski syndrome, Pitt-Hopkins syndrome and mental retardation type 1, will not only improve the understanding of these respective syndromes but also provide useful insights into the complex nature of brain disorders, including autism spectrum disorders.
No takes yet. Share an insight, caveat, or question.
Toshihiko Ezashi (2013) studied this question.
Synapse has enriched 6 related papers. Consider them for comparative context: